Abstract：Objective: To investigate the role of lysine demethylase 5B(KDM5B)/ enhanced activated transcription factor 3(ATF3) signaling pathway in angiotensin Ⅱ (Ang-Ⅱ)-induced cardiac hypertrophy.Methods: Mouse cardiomyocytes HL-1 were divided into the following treatment groups: control group, Ang-Ⅱ group, Ang-Ⅱ+Lv-NC group, Ang-Ⅱ+Lv-KDM5B group and Ang-Ⅱ+LV-KDM5KD group. The expression of KDM5B and ATF3 protein in cells of each group was analyzed by protein blot. The intracellular levels of α -actin (α-SMA), Fe2+ and reactive oxygen species (ROS) were detected by fluorescence staining. Results: Compared with Ang-Ⅱ+Lv-NC group, the expression of KDM5B protein in HL-1 cells in Ang-Ⅱ+Lv-KDM5B group increased significantly (P<0.05), and the expression of ATF3 protein decreased significantly (P<0.05), while the expression of KDM5B protein in HL-1 cells in Ang-Ⅱ+Lv-KDM5B KD group decreased significantly (P<0.05). Compared with the control group, the relative cell size, intracellular relative Fe2+ fluorescence intensity and relative ROS fluorescence intensity in Ang-Ⅱ group and Ang-Ⅱ+Lv-NC group increased significantly (P<0.05), and the relative cell viability decreased significantly (P<0.05). Compared with Ang-Ⅱ+Lv-NC group, the relative cell size, intracellular relative Fe2+ fluorescence intensity and relative ROS fluorescence intensity in Ang-Ⅱ+Lv-KDM5B group increased significantly (P<0.05), while the relative cell size, intracellular relative Fe2+ fluorescence intensity and relative ROS fluorescence intensity in Ang-Ⅱ+Lv-KDM5B KD group decreased significantly (P<0.05).Conclusion: KDM5B/ATF3 drives the progress of Ang-Ⅱ-induced myocardial hypertrophy and promotes ferroptosis related to hypertrophic stress response.
王欣婷, 徐萌萌, 孔雪, 冯洪亮, 杨建. Ang-Ⅱ介导的铁死亡参与房颤触发及心衰进展的机制研究[J]. 河北医学, 2024, 30(6): 886-892.
WANG Xinting, XU Mengmeng, KONG Xue, et al. Mechanism Study on Ang -Ⅱ Mediated Ferroptosis in Triggering Atrial Fibrillation and Progression of Heart Failure. HeBei Med, 2024, 30(6): 886-892.
[1] Bhullar S K,Dhalla N S.Angiotensin Ⅱ-induced signal transduction mechanisms for cardiac hypertrophy[J].Cells,2022,11(21):3336. [2] McKinsey T A,Foo R,Anene-Nzelu C G,et al.Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure:from basic mechanisms to early clinical development[J].Cardiovasc Res,2022,118(18):3482-3498. [3] Zhang K,Tian X M,Li W,et al.Ferroptosis in cardiac hypertrophy and heart failure[J].Biomed Pharmacother,2023(168):115765. [4] Liu Z Y,Song K,Tu B,et al.Crosstalk between oxidative stress and epigenetic marks:New roles and therapeutic implications in cardiac fibrosis[J].Redox Biol,2023(65):102820. [5] Wang Z,Xia Q,Su W,et al.Exploring the communal pathogenesis,ferroptosis mechanism,and potential therapeutic targets of dilated cardiomyopathy and hypertrophic cardiomyopathy via a microarray data analysis[J].Front Cardiovasc Med,2022(9):824756. [6] Wang Y,Chen D,Xie H,et al.LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter[J].Mol Med,2023,29(1):32. [7] Yoo J,Kim G W,Jeon Y H,et al.Drawing a line between histone demethylase KDM5A and KDM5B:their roles in development and tumorigenesis[J].Exp Mol Med,2022,54(12):2107-2117. [8] Wang B,Tan Y,Zhang Y,et al.Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression[J].Exp Mol Med,2022,54(12):2175-2187. [9] Yang Y,Wang X,Yan P,et al.Transmembrane protein 117 knockdown protects against angiotensin-Ⅱ-induced cardiac hypertrophy[J].Hypertens Res,2023,46(10):2326-2339. [10] Costa S,Cerrone M,Saguner AM,et al.Arrhythmogenic cardiomyopathy:an in-depth look at molecular mechanisms and clinical correlates[J].Trends Cardiovasc Med,2021,31(7):395-402. [11] Coscarella IL,Landim-Vieira M,Rastegarpouyani H,et al.Nucleus mechanosensing in cardiomyocytes[J].Int Mol Sci,2023,24(17):13341. [12] Sopic M,Robinson EL,Emanueli C,et al.Integration of epigenetic regulatory mechanisms in heart failure[J].Basic Res Cardiol,2023,118(1):16. [13] Zhang SM,Cai WL,Liu X,et al.KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements[J].Nature,2021,598(7882):682-687. [14] Soraya AS,Tali H,Rona S,et al.ATF3 expression in cardiomyocytes and myofibroblasts following transverse aortic constriction displays distinct phenotypes[J].Int Cardiol Heart Vasc,2020(32):100706. [15] Bedoui S,Herold MJ,Strasser A.Emerging connectivity of programmed cell death pathways and its physiological implications[J].Nat Rev Mol Cell Biol,2020,21(11):678-695. [16] Li S,Huang Y.Ferroptosis:an iron-dependent cell death form linking metabolism,diseases,immune cell and targeted therapy[J].Clin Transl Oncol,2022,24(1):1-12. [17] Liu Y,Hu Y,Xiong J,et al.Overexpression of activating transcription factor 3 alleviates cardiac microvascular ischemia/reperfusion injury in rats[J].Front Pharmacol,2021(12):598959.
2024, Vol. 30 
冀公网安备13080202000677号